Does the funding source influence the results in economic evaluations? A case study in bisphosphonates for the treatment of osteoporosis.

Does the funding source influence the results in economic evaluations? A case study in bisphosphonates for the treatment of osteoporosis.

Item
http://www.wikidata.org/entity/Q37707358
Industry involvement and baseline assumptions of cost-effectiveness analyses: diagnostic accuracy of the Papanicolaou test.When are statins cost-effective in cardiovascular prevention? A systematic review of sponsorship bias and conclusions in economic evaluations of statins.Health technology assessment in osteoporosis.Cost-effectiveness of strontium ranelate for the prevention and treatment of osteoporosis.Sponsorship-related outcome selection bias in published economic studies of triptans: systematic review.A review of the costs and cost effectiveness of interventions in chronic kidney disease: implications for policy.Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporotic women.A systematic review of cost-effectiveness analyses of drugs for postmenopausal osteoporosis.Assessing the Quality of Economic Evaluations of FDA Novel Drug Approvals: A Systematic Review.A systematic review of health economic evaluations of vaccines in Brazil.
P2860

Does the funding source influence the results in economic evaluations? A case study in bisphosphonates for the treatment of osteoporosis.

Item
http://www.wikidata.org/entity/Q37707358
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Does the funding source influe ...... the treatment of osteoporosis.
@en
Does the funding source influe ...... the treatment of osteoporosis.
@nl
type
label
Does the funding source influe ...... the treatment of osteoporosis.
@en
Does the funding source influe ...... the treatment of osteoporosis.
@nl
prefLabel
Does the funding source influe ...... the treatment of osteoporosis.
@en
Does the funding source influe ...... the treatment of osteoporosis.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921
P356
P1433
P1476
Does the funding source influe ...... the treatment of osteoporosis.
@en
P2093
P2860
P2888
P304
P31
P356
10.2165/11530530-000000000-00000
P433
P478
P577
P6179
P698
P921